HIMS
Hims & Hers Health, Inc. [HIMS] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HIMS Stock Summary
Top HIMS Correlated Resources
HIMS
Top 10 Correlated ETFs
HIMS
Top 10 Correlated Stocks
HIMS
In the News
HIMS Financial details
Company Rating
Neutral
Market Cap
2.87B
Income
-23.55M
Revenue
872M
Book val./share
1.63
Cash/share
1.04
Dividend
-
Dividend %
-
Employees
1.05K
Optionable
No
Shortable
Yes
Earnings
06 May 2024
P/E
-50.27
Forward P/E
-
PEG
7.77
P/S
2.28
P/B
5.46
P/C
11.37
P/FCF
67.37
Quick Ratio
2.63
Current Ratio
3.03
Debt / Equity
0.03
LT Debt / Equity
0.03
-
-
EPS (TTM)
-0.11
EPS next Y
-
EPS next Q
-
EPS this Y
-65.63%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-47.88%
Revenue last 5Y
60.23%
Revenue Q/Q
8.79%
EPS Q/Q
-116.39%
-
-
-
-
SMA20
-18.75%
SMA50
44.44%
SMA100
62.5%
Inst Own
44.38%
Inst Trans
0.75%
ROA
-9%
ROE
-11%
ROC
-0.12%
Gross Margin
81%
Oper. Margin
-5%
Profit Margin
-5%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
5.65-17.16
52W High
-30.47%
52W Low
+136.4%
RSI
31
Rel Volume
0.79
Avg Volume
4.86M
Volume
3.85M
Perf Week
-19.04%
Perf Month
-17.11%
Perf Quarter
104.5%
Perf Half Y
86.73%
-
-
-
-
Beta
0.908
-
-
Volatility
0.65%, 1.3%
Prev Close
-4.21%
Price
11.82
Change
-3.9%
HIMS Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
| Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 3.28 | 4.21 | 1.46 | 2.58 | 4.17 | |
| Net income per share | -2.86 | -0.51 | -0.58 | -0.32 | -0.11 | |
| Operating cash flow per share | -2.98 | -0.07 | -0.18 | -0.13 | 0.36 | |
| Free cash flow per share | -3.05 | -0.19 | -0.21 | -0.17 | 0.23 | |
| Cash per share | 2.4 | 2.83 | 1.32 | 0.88 | 1.06 | |
| Book value per share | -5.38 | -4.15 | 1.79 | 1.52 | 1.64 | |
| Tangible book value per share | -5.43 | -4.16 | 1.06 | 0.88 | 1.02 | |
| Share holders equity per share | -5.38 | -4.15 | 1.79 | 1.52 | 1.64 | |
| Interest debt per share | 0.07 | 0.12 | 0.03 | 0.01 | 0.05 | |
| Market cap | 249.05M | 516.17M | 1.22B | 1.31B | 1.86B | |
| Enterprise value | 227.91M | 488.82M | 1.16B | 1.27B | 1.78B | |
| P/E ratio | -3.46 | -28.5 | -11.36 | -19.96 | -79.13 | |
| Price to sales ratio | 3.02 | 3.47 | 4.5 | 2.49 | 2.14 | |
| POCF ratio | -3.33 | -208.22 | -35.55 | -49.41 | 24.71 | |
| PFCF ratio | -3.25 | -76.9 | -31.04 | -38.81 | 38.08 | |
| P/B Ratio | -1.84 | -3.51 | 3.66 | 4.21 | 5.42 | |
| PTB ratio | -1.84 | -3.51 | 3.66 | 4.21 | 5.42 | |
| EV to sales | 2.76 | 3.29 | 4.26 | 2.41 | 2.04 | |
| Enterprise value over EBITDA | -3.15 | -28.89 | -10.47 | -20.74 | -74.19 | |
| EV to operating cash flow | -3.04 | -197.18 | -33.63 | -47.85 | 23.56 | |
| EV to free cash flow | -2.97 | -72.83 | -29.35 | -37.58 | 36.31 | |
| Earnings yield | -0.29 | -0.04 | -0.09 | -0.05 | -0.01 | |
| Free cash flow yield | -0.31 | -0.01 | -0.03 | -0.03 | 0.03 | |
| Debt to equity | -0.01 | -0.03 | 0.02 | 0.02 | 0.03 | |
| Debt to assets | 0.02 | 0.04 | 0.01 | 0.01 | 0.02 | |
| Net debt to EBITDA | 0.29 | 1.62 | 0.6 | 0.68 | 3.62 | |
| Current ratio | 3.38 | 7.43 | 3.41 | 4.52 | 3 | |
| Interest coverage | -201.66 | -1.51K | 0 | 22.99 | 0 | |
| Income quality | 1.04 | 0.14 | 0.32 | 0.4 | -3.2 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | -0.1 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.68 | 0.44 | 0.68 | 0.19 | 0.15 | |
| Research and developement to revenue | 0 | 0.08 | 0.08 | 0.06 | 0.06 | |
| Intangibles to total assets | 0.02 | 0 | 0.33 | 0.36 | 0.29 | |
| Capex to operating cash flow | 0.02 | 1.71 | 0.15 | 0.27 | -0.35 | |
| Capex to revenue | -0.02 | -0.03 | -0.02 | -0.01 | -0.03 | |
| Capex to depreciation | -6.87 | -4 | -1.23 | -0.97 | -2.78 | |
| Stock based compensation to revenue | 0.1 | 0.04 | 0.25 | 0.08 | 0.08 | |
| Graham number | 18.62 | 6.92 | 4.82 | 3.32 | 2.04 | |
| ROIC | 0.56 | 0.11 | -0.32 | -0.21 | -0.1 | |
| Return on tangible assets | -1.02 | -0.15 | -0.38 | -0.28 | -0.08 | |
| Graham Net | -5.73 | -4.6 | 0.91 | 0.68 | 0.67 | |
| Working capital | 48.99M | 97.86M | 190.68M | 168.65M | 176.59M | |
| Tangible asset value | -136.59M | -146.93M | 197.85M | 179.02M | 214.57M | |
| Net current asset value | -137.76M | -152.49M | 183.94M | 162M | 167.9M | |
| Invested capital | -0.01 | -0.03 | 0.02 | 0.02 | 0.03 | |
| Average receivables | 0 | 1M | 2.36M | 3.4M | 4.47M | |
| Average payables | 0 | 7.65M | 13.85M | 26M | 37.72M | |
| Average inventory | 0 | 3.88M | 8.55M | 17.56M | 22.01M | |
| Days sales outstanding | 3.8 | 2.81 | 4.8 | 2.24 | 2.39 | |
| Days payables outstanding | 69.54 | 74.9 | 106.38 | 99.94 | 94.38 | |
| Days of inventory on hand | 40.56 | 32.9 | 73.44 | 66.59 | 49.23 | |
| Receivables turnover | 96.11 | 129.69 | 76.01 | 163.08 | 152.85 | |
| Payables turnover | 5.25 | 4.87 | 3.43 | 3.65 | 3.87 | |
| Inventory turnover | 9 | 11.09 | 4.97 | 5.48 | 7.41 | |
| ROE | 0.53 | 0.12 | -0.32 | -0.21 | -0.07 | |
| Capex per share | -0.07 | -0.12 | -0.03 | -0.04 | -0.13 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
| Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
|---|---|---|---|---|---|---|
| 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
| Revenue per share | 0.81 | 0.92 | 1 | 1.08 | 1.17 | |
| Net income per share | -0.05 | -0.05 | -0.03 | -0.04 | 0.01 | |
| Operating cash flow per share | -0.03 | 0.05 | 0.08 | 0.12 | 0.11 | |
| Free cash flow per share | -0.05 | 0.03 | 0.05 | 0.09 | 0.06 | |
| Cash per share | 0.87 | 0.89 | 0.93 | 1.01 | 1.04 | |
| Book value per share | 1.51 | 1.51 | 1.54 | 1.56 | 1.63 | |
| Tangible book value per share | 0.87 | 0.87 | 0.91 | 0.94 | 1.01 | |
| Share holders equity per share | 1.51 | 1.51 | 1.54 | 1.56 | 1.63 | |
| Interest debt per share | 0.01 | 0.02 | 0.02 | 0.02 | 0.05 | |
| Market cap | 1.32B | 2.05B | 1.96B | 1.32B | 1.88B | |
| Enterprise value | 1.28B | 2.01B | 1.9B | 1.27B | 1.8B | |
| P/E ratio | -30.29 | -51.03 | -68.44 | -43.67 | 378.13 | |
| Price to sales ratio | 7.9 | 10.77 | 9.42 | 5.83 | 7.64 | |
| POCF ratio | -196.66 | 216.69 | 116.44 | 52.47 | 78.74 | |
| PFCF ratio | -141.59 | 294.68 | 196.66 | 68.59 | 148.07 | |
| P/B Ratio | 4.24 | 6.57 | 6.12 | 4.02 | 5.47 | |
| PTB ratio | 4.24 | 6.57 | 6.12 | 4.02 | 5.47 | |
| EV to sales | 7.65 | 10.54 | 9.13 | 5.6 | 7.28 | |
| Enterprise value over EBITDA | -110.29 | -219.88 | -276.84 | -204.88 | -296.14 | |
| EV to operating cash flow | -190.49 | 212.06 | 112.85 | 50.35 | 75.11 | |
| EV to free cash flow | -137.15 | 288.4 | 190.61 | 65.82 | 141.25 | |
| Earnings yield | -0.01 | 0 | 0 | -0.01 | 0 | |
| Free cash flow yield | -0.01 | 0 | 0.01 | 0.01 | 0.01 | |
| Debt to equity | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | |
| Debt to assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | |
| Net debt to EBITDA | 3.57 | 4.79 | 8.8 | 8.61 | 14.3 | |
| Current ratio | 4.52 | 4.01 | 3.53 | 3.03 | 3 | |
| Interest coverage | 4.49 | 7.12 | 0 | 0 | 0 | |
| Income quality | 0.62 | -0.94 | -2.35 | -3.33 | 19.21 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0.16 | 0.16 | 0.15 | 0.16 | 0.13 | |
| Research and developement to revenue | 0.05 | 0.06 | 0.06 | 0.05 | 0.05 | |
| Intangibles to total assets | 0.36 | 0.35 | 0.34 | 0.31 | 0.29 | |
| Capex to operating cash flow | 0.39 | -0.26 | -0.41 | -0.24 | -0.47 | |
| Capex to revenue | -0.02 | -0.01 | -0.03 | -0.03 | -0.05 | |
| Capex to depreciation | -1.3 | -1.19 | -2.89 | -2.51 | -4.21 | |
| Stock based compensation to revenue | 0.07 | 0.07 | 0.08 | 0.08 | 0.07 | |
| Graham number | 1.34 | 1.28 | 1.09 | 1.13 | 0.46 | |
| ROIC | -0.04 | -0.04 | -0.03 | -0.03 | -0.01 | |
| Return on tangible assets | -0.05 | -0.04 | -0.03 | -0.03 | 0 | |
| Graham Net | 0.67 | 0.65 | 0.66 | 0.67 | 0.66 | |
| Working capital | 168.65M | 169.24M | 168.1M | 167.67M | 176.59M | |
| Tangible asset value | 179.02M | 180.96M | 189.23M | 198.38M | 214.57M | |
| Net current asset value | 162M | 161.96M | 164.84M | 164.92M | 167.9M | |
| Invested capital | 0.02 | 0.02 | 0.02 | 0.01 | 0.03 | |
| Average receivables | 3.52M | 3.85M | 4.19M | 4.07M | 4.97M | |
| Average payables | 32.67M | 34.99M | 37.94M | 40.13M | 42.54M | |
| Average inventory | 21.95M | 21.13M | 21.06M | 21.7M | 22.23M | |
| Days sales outstanding | 1.74 | 2.11 | 1.69 | 1.68 | 2.08 | |
| Days payables outstanding | 83.54 | 90.64 | 91.22 | 95.96 | 85.72 | |
| Days of inventory on hand | 55.66 | 49.88 | 51.05 | 50.25 | 44.71 | |
| Receivables turnover | 51.75 | 42.63 | 53.28 | 53.61 | 43.23 | |
| Payables turnover | 1.08 | 0.99 | 0.99 | 0.94 | 1.05 | |
| Inventory turnover | 1.62 | 1.8 | 1.76 | 1.79 | 2.01 | |
| ROE | -0.03 | -0.03 | -0.02 | -0.02 | 0 | |
| Capex per share | -0.01 | -0.01 | -0.03 | -0.03 | -0.05 |
HIMS Frequently Asked Questions
What is Hims & Hers Health, Inc. stock symbol ?
Hims & Hers Health, Inc. is a US stock , located in San francisco of Ca and trading under the symbol HIMS
What is Hims & Hers Health, Inc. stock quote today ?
Hims & Hers Health, Inc. stock price is $11.82 today.
Is Hims & Hers Health, Inc. stock public?
Yes, Hims & Hers Health, Inc. is a publicly traded company.
Company Profile
- Volume Average 4.86M
- Market Capitalization 2.87B
- Employee 1.05K
- CEO Mr. Andrew Dudum
- Headquarters San Francisco,CA,US
- IPO Date 2019-09-13
-
Website
https://www.forhims.com 
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products, primarily focusing on wellness, sexual health and wellness, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, biotin, and collagen protein supplements in the wellness category; moisturizer, serums, and face wash in the skincare category; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. In addition, it offers medical consultation services, as well as health and wellness products through wholesale partners. The company is based in San Francisco, California.
